Summit Therapeutics Inc. (SMMT)

Model N Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	297.87	104.86	71.43	348.61	71.79	66.42
Short-Term Investments	-	307.49	114.82	-	-	-
Cash & Short-Term Investments	297.87	412.35	186.24	348.61	71.79	66.42
Cash Growth	-8.48%	121.41%	-46.58%	385.59%	8.09%	4.03%
Accounts Receivable	-	-	-	0.35	1.46	0.33
Other Receivables	-	0.56	0.85	5.77	15.7	9.86
Receivables	-	0.56	0.85	6.12	17.16	10.19
Prepaid Expenses	11.05	10.52	2.62	1.5	7.16	9.55
Restricted Cash	0.32	0.33	-	300	-	-
Other Current Assets	-	-	-	0.49	1.2	1.52
Total Current Assets	309.24	423.75	189.71	656.71	97.31	87.67
Property, Plant & Equipment	6.24	7.4	6.06	5.08	3.48	1.28
Goodwill	2.04	1.86	1.89	1.8	2.01	2.03
Other Intangible Assets	-	-	-	-	10.4	11.52
Other Long-Term Assets	6.52	2.55	5.28	0.58	0.17	-
Total Assets	324.04	435.56	202.95	664.17	113.37	102.5
Accounts Payable	22.98	4.64	2.67	0.36	4.37	6.14
Accrued Expenses	32.74	31.53	14.21	16.31	11.32	4.26
Current Portion of Long-Term Debt	-	-	-	19.77	-	-
Current Portion of Leases	3.12	3.77	2.81	1.69	1.09	0.39
Current Unearned Revenue	-	-	-	-	7.94	8.37
Other Current Liabilities	1.49	1.8	0.72	0.66	0.9	0.73
Total Current Liabilities	60.33	41.73	20.41	38.78	25.62	19.89
Long-Term Debt	-	-	100	494.54	-	-
Long-Term Leases	2.44	3.45	3.29	2.76	1.69	0.08
Long-Term Unearned Revenue	-	-	-	-	-	0.57
Other Long-Term Liabilities	1.84	1.63	1.56	1.43	2.78	2.51
Total Liabilities	64.6	46.81	125.26	537.51	30.09	23.05
Common Stock	7.43	7.38	7.02	2.11	0.98	0.83
Additional Paid-In Capital	2,098	1,598	1,066	504.77	384.05	293.37
Retained Earnings	-1,843	-1,215	-993.26	-378.33	-299.55	-210.95
Comprehensive Income & Other	-2.75	-2.29	-2.45	-1.89	-2.2	-3.79
Shareholders' Equity	259.44	388.75	77.69	126.65	83.28	79.45
Total Liabilities & Equity	324.04	435.56	202.95	664.17	113.37	102.5
Total Debt	5.55	7.22	106.1	518.76	2.78	0.47
Net Cash (Debt)	292.32	405.13	80.14	-170.16	69.01	65.95
Net Cash Growth	34.86%	405.51%	-	-	4.63%	4.77%
Net Cash Per Share	0.40	0.56	0.13	-0.88	0.75	0.95
Filing Date Shares Outstanding	742.85	737.68	701.7	697.69	98.12	82.92
Total Common Shares Outstanding	742.81	737.63	701.66	211.09	98.04	82.58
Working Capital	248.92	382.02	169.31	617.93	71.69	67.78
Book Value Per Share	0.35	0.53	0.11	0.60	0.85	0.96
Tangible Book Value	257.4	386.88	75.8	124.86	70.88	65.91
Tangible Book Value Per Share	0.35	0.52	0.11	0.59	0.72	0.80
Machinery	-	1.05	0.92	1.39	1.37	1.56
Leasehold Improvements	-	0.32	0.33	0.81	0.37	0.29

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q